loader image
Saturday, December 20, 2025
77.8 F
McAllen
- Advertisement -

New Blog Highlights EmPOWERed Health

Translate to Spanish or other 102 languages!

Mega Doctor News

- Advertisement -

One question sparked it all: Could the number of cancer deaths be lowered by empowering people to take a more active role in their health? Learn from CDC’s Dr. Lisa Richardson about how EmPOWERed Health, a new CDC and CDC Foundation program, is aiming to improve cancer prevention and outcomes. Dr. Richardson shares the goals of EmPOWERed Health and the importance of empowering individuals to seek the care they need for cancer prevention and treatment, and to take actions to stay healthy: “Empowerment can result in more people getting cancer screenings, a greater feeling of control during cancer diagnosis and treatment, and a better care plan for cancer survivors.”

Several members of the EmPOWERed Health community also share how empowerment has made a difference in their physical and mental health. Join the EmPOWERed Health community on Instagram.

Learn More

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.

DHR Health and Brownsville Join Forces on Major Hospital Expansion

The City of Brownsville and DHR Health announced a new public-private partnership to expand DHR Health Brownsville, marking a major investment in local healthcare and economic development

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.
- Advertisement -
×